Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Shira Engelberg

Israel Institute of Technology Israel

Mark McLaughlin

Merck Sharp & Dohme (MSD) Dept. of Process Research and Development USA

Dorota Dobler

University of Applied Sciences Germany

Francisco Alonso

Universidad de Alicante Spain

Vasiliki Daikopoulou

Greece

Ming-Chao Huang

Taipei Veterans General Hospital Taiwan

Young-Hyo-Kim

Inha University College of Medicine Spain

Vladimir-S-Naumenko

Institute of Cytology and Genetics Russia

Pharmatech 2025

About Conference


Conference Series LLC Ltd extends its welcome to join "7th International Conference and Exhibition on Pharmaceutical Development and Technology" during June 10-11, 2025 at Vancouver, Canada with a theme “Innovations & Reforms in Pharmaceutical & Pharma Industry". Conference Series LLC Ltd organized 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharmacy, Engineering, Science, Technology and Business. We are running the conferences across the globe from the past 10 years.

Conference Name

                Place

              Date

Pharmatech 2025

      Vancouver, Canada

June 10-11, 2025

 

Session and Tracks

Track-01 Challenges In Pharmaceutical Formulations

Pharmaceutical formulation is defined as the process in which different chemical substances are combined to produce a final medicinal product. The formulation studies involve developing a preparation of drug acceptable for patient. Formulation is the word often used in a way that includes dosage form. Formulation studies consider factors such as solubility, particle size, polymorphism and pH as all of these can influence bioavailability and hence the activity of a drug.

  • Pharmaceutical Excipients
  • Pharmaceutical Product Development
  • Types of Drug Formulation
  • Ophthalmic Formulation
  • Paediatric Formulation Development
  • Medication Formulation
  • Topical Formulations

Track-02 Innovations In Pharmaceutical Technology

This session is of Pharmaceutical technology which is the application of scientific knowledge or technology to pharmacy, pharmacology, and the pharmaceutical industry. It describes techniques, designs, and instrumentation in the preparation, compounding, manufacturing, and packaging, dispensing and accumulating of narcotic and other preparations used in diagnostic and determinative procedures and in the treatment of patients.

This track represents Technology Transfer Pharmaceutical Technology Assessment Quality assurance Bioinformatics and Computational Biology Pharmacological Technology advances Pharmaceutical Packaging and labelling.

  • Technology Transfer
  • Pharmaceutical Technology Assessment
  • Quality assurance
  • Bioinformatics and Computational Biology
  • Pharmacological Technology advances
  • Pharmaceutical Packaging and labelling

Track-03 Pharmaceutical Research and Development

For developing a new medicine it will take nearly 10-15 years and on average and costs an average of $2.6 billion. In discovery procedure comprises the initial stages of research, which are intended to recognize an investigational drug and perform primary tests in the lab. This first stage of the process takes   three to six years. By the end, investigators hope to identify a capable drug aspirant to further study in the lab and in animal models, and then in people. These developments offer great ability, but also add complexity to the R&D process. In order to ensure the safety and efficacy of personalized therapies that are used along with diagnostics, clinical trial protocols must be improved and increased.

  • Analytical strategies for pharmaceutical products
  • Recent trends in Drug Discovery and Development
  • Pharmacoeconomics and pharma market research
  • Drug Prices and Consumer Value in R&D
  • Stability of drugs
  • The Audit as a Quality Control Mechanism

Track- 04 Pharmaceutical Industry

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs.

  • Serialization in pharmaceutical industry
  • Track and trace in pharma
  • GDP Good Distribution Practice
  • GMP a legal requirement

Track-05 Pharmaceutical Science

Pharmaceutical Sciences combine a wide range of scientific disciplines that are essential to the discovery and development of new drugs and therapies. Pharmaceutical sciences can be classified into the following broad categories, with many specialized areas within each category.

Over the years, pharmaceutical scientists have been instrumental in the discovery and development of innovative drugs that have saved the lives of thousands of people and improved the quality of life for many others. Pharmaceutical scientists can work in a variety of jobs. They are employed by pharmaceutical companies, they work as pharmacists, physicians, researchers and professors at universities, as regulatory scientists for agencies such as the Food and Drug Administration (FDA), and as researchers at national laboratories such as the National Institutes of Health (NIH).

Track-06 Drug Discovery and Development

Drug discovery is a process in pharmacy which involves the interaction of various disciplines leading to the invention of potent drug entities. The major part of drug design involves the identification of characteristic diagnostic biomarkers such as a protein responsible for the disease or disorder and then developing a drug molecule of therapeutic potency that targets it. The process involves various branches of pharmacology coalesce with biotechnology, bioinformatics, molecular biology, nanotechnology and biochemistry that ultimately leads to the production of molecules of therapeutic value.

  • Diagnostic markers as therapeutic targets
  • Approaches in target identification and validation
  • In Silicon Structured Based Drug Design
  • Drug design and molecular Modelling
  • Molecular docking studies

Track-07 Drug Targeting and Design

Drug Design Conferences, often referred to as rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. The drug is most commonly an organic small molecule that activates or inhibits the function of a biomolecule such as a protein, which in turn results in a therapeutic benefit to the patient. In the most basic sense, drug design involves the design of molecules that are complementary in shape and charge to the bimolecular target with which they interact and therefore will bind to it. Drug design frequently but not necessarily relies on computer modelling techniques. This type of modelling is sometimes referred to as computer-aided drug design. Finally, drug design that relies on the knowledge of the three-dimensional structure of the bimolecular target is known as structure-based drug design. In addition to small molecules, biopharmaceuticals and especially therapeutic antibodies are an increasingly important class of drugs and computational methods for improving the affinity, selectivity, and stability of this protein-based therapeutics have also been developed.

  • Biomarkers in drug discovery
  • Genetics in drug development
  • Computer – aided drug design
  • Rational drug design approach

Track-08 Smart Drug Delivery Systems

Smart drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. This means of delivery is largely founded on Nano medicine, which plans to employ nanoparticle-mediated drug delivery in order to combat the downfalls of conventional drug delivery. These nanoparticles would be loaded with drugs and targeted to specific parts of the body where there is solely diseased tissue, thereby avoiding interaction with healthy tissue. The goal of targeted drug delivery systems is to prolong, localize, target and have a protected drug interaction with the diseased tissue. The conventional drug delivery system is the absorption of the drug across a biological membrane, whereas the targeted release system releases the drug in a dosage form. The advantages to the targeted release system is the reduction in the frequency of the dosages taken by the patient, having a more uniform effect of the drug, reduction of drug side-effects, and reduced fluctuation in circulating drug levels. The disadvantage of the system is high cost, which makes productivity more difficult and the reduced ability to adjust the dosages.

  • Microbial examination of non-sterile products
  • Investigating USP sterility testing failure
  • Bio burden estimation for medical devices
  • Rapid screening methods

Track-09 Pharmaceutical Analysis

Pharmaceutical Analysis is a process or a sequence of processes to identify and/or quantify a substance or drug, the components of a pharmaceutical solution or mixture or the determination of the structures of chemical compounds used in the formulations 2019 of pharmaceutical product. Analytical techniques conferences mainly used for the separation of the components from the mixture and for the determination of the structure of the compounds.

  • Health Insurance Portability and Accountability
  • Implementing effective compliance policies

Track-10 Pharmaceutical Chemistry

Pharmaceutical Chemistry is the study of drug design to optimize pharmacokinetics and pharmacodynamics, and synthesis of new drug molecules. Pharmaceutical Chemistry is a branch of chemistry that deals with the chemical, biochemical and pharmacological aspects of drugs. It includes synthesis/isolation, identification, structural elucidation, structural modification, structural activity relationship (SAR) studies, and study of the chemical characteristics, biochemical changes after drug administration and their pharmacological effects as well as analysis of drugs. In more simple words it is broader than medicinal chemistry in its application also in the fields of analysis, identification, as well as, structural elucidation of drugs.

  • Drug discovery & drug development
  • Drug targets molecular imaging

Track-11 Digital Pharma

Pharmaceutical digital marketing is the use of strategies and technologies to promote products to the right audiences across digital channels. It's an opportunity for pharm brands to leverage cost-effective digital marketing strategies to connect with consumers and healthcare providers.

  • Educate audiences with content marketing. Content marketing is the practice of writing, designing, and publishing information online.
  • Build a trustworthy brand with reputation management.
  • Interact with audiences using social media.
  • Increase feedback value with review management.

Track-12 Drug Product Manufacturing

The drug product manufacturing facility is designed to produce injectable in syringes or vials in Grade an environment. Industries strive to improve product quality in today’s competitive environment and as well reduce the production cost.

  • Pre and post gas flushing facility
  • Sterile filtration, aseptic filling
  • Process development tools
  • Stability testing
  • Capping, Sealing & Labelling
  • Storage and handling of cold-chain products

Track-13 Pharmacists Role in Patient Safety

Pharmacists can play a role helping patients with chronic diseases have better medication at correct time and get good clinical outcomes.  They play a key role in immunization services and identifying vaccine candidates. They Participate and maintain a significant role in multidisciplinary patient care rounds. Patients often make their own decisions about managing their medications. Pharmacists could usefully serve as patient advocates, providing information that permits patients to assess risk and enhance their autonomy.

  • Key role in reducing adverse drug events
  • Patient counselling
  • Communication barriers
  • Medical controversies
  • Legal and practical aspects of prescribing
  • Improving patient care in rural areas
  • Reducing healthcare costs
  • Improving patient safety

Track-14 Pharmaceutics and Pharmacotherapeutics

Pharmaceutics encompasses a molecular evaluation of drug metabolism and transport processes and the study of genetic, environmental and disease-related factors that regulate or perturb those processes, as well as the fundamental mathematical relationships between enzyme/transporter function, blood concentration-time profiles and the spectrum of pharmacological effects.

Pharmacotherapeutics is treatment of pathologic conditions through the use of drugs. Pharmacists are specialists in pharmacotherapy and are in charge of guaranteeing the protected, suitable, and prudent utilization of pharmaceutical medications.

  • New Chemical Entity
  • Pharmaceutical Manufacturing
  • Reformulation Considerations
  • Pharmaceutical Technology
  • Advances in Pharmacodynamics & Pharmacokinetics

Track-15 Pharmacology

Pharmacology is a branch of medicine, biology and pharmaceutical sciences concerned with drug or medication action, where a drug may be defined as any artificial, natural, or endogenous (from within the body) molecule which exerts a biochemical or physiological effect on the cell, tissue, organ, or organism (sometimes the word pharmacon is used as a term to encompass these endogenous and exogenous bioactive species). More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals.

Benefits of Participation

Advantages of Participating at our conference:

  • As an add on advantage the Speaker & Abstract pages created in Google on your profile under your name would get worldwide visibility
  • Our robust online publicity attracts 20000+ users and 60000+ views to our Library of Abstracts which brings worldwide exposure to the researchers and speakers participate in our conferences
  • All the conference participants can earn up to 16-18 CME Credits by participating at our Pharmatech – 2024 Conference scheduled as a January 11-12, 2024 Dubai, UAE
  • To attain professional development we offer our participants a chance to earn up to 21 CPD Credits authorized by CPD Standards Office, UK by participating at our Pharmatech- 2024 Conferences.
  • All the conference participants will be awarded with IOCM Certification.
  • All the conference participants will have an unique opportunity to participate at One on One Meeting with Eminent Speakers
  • A Unique opportunity to hear what the global researchers are talking about at our Keynote sessions by world’s most eminent researchers in the field of Pharmatech- 2024.
  • Top Industries Representation of Industrial Leaders, where you get a great opportunity to meet and discuss with the Industrial Leaders in person
  • Thought provoking Symposia’s
  • Workshops on Carrier Development
  • Preconference workshops in all major countries
  • Nominations for Best Poster Award
  • Outstanding Young Researcher Award
  • Group Registration benefits

Benefits of Participation | Speaker

  • Explore the best in Cutting edge Research
  • Worldwide acknowledgment of Researcher’s profile
  • Obtain professional development credits
  • Your presence and talk will be recorded and hosted on YouTube and Video which in turn will gain potential value to your research profile.
  • Make Lasting connections at Networking and Social Events
  • We provide unique convergence of Networking, Learning and Fun into a single package
  • An opportunity to give One page advertisement in abstract book and flyers distribution which eventually gets 1 Million views and add great value to your research profile
  • Learn beyond your field of interest, a change to know more about the new topics and research apart from your core subject

Benefits of Participation | Delegate

  • Helps to meet Experts & Influencers Face to Face.
  • Opportunities to meet researchers and experts of same field and share new ideas
  • Can help to know New Tips & Tactics
  • Professional Development – Elevate your knowledge and Skills
  • Conference attendance inspires, rejuvenates, and energizes delegates
  • Your participation at our conference will be helpful for a new approach and ideology that can be utilized for the extending the outcome of Companies or Industries.
  • Enjoy the alluring city environment where the conference is being held.
  • Raise your profile by being well-known

Benefit of Participation | Sponsor

  • Worlds No1 Platform to show case Pharmatech- 2024 Products
  • Exposure to the international atmosphere will increase the odds of getting new business
  • Opportunity to showcase the new technology, new products of your company, and/or the service your industry to a broad international audience
  • Attain with an exceptional format in showcasing the products and services and to gain the potential clients for the future business prospects
  • Our Pharmatech- 2024 Conference in the One and only location to reach the top customers
  • Make new connections and fostering potential partnerships
  • Increase your business by lead generation through our conference participants.
  • Build a successful business takes a lot of time, effort and drive, so it’s always good to have a network of colleagues and associates to draw energy from people who share a similar drive and objective.
  • Flip side of learning new things is relearning classic techniques. Pharmatech- 2024 conferences create opportunities for greater focus and reflection that could help you take your business to the next level.
  • Benchmarking key strategies for business and moving it forward
  • Get answers to your business questions and challenges from credible individuals at our conference
  • Exposure and Networking Opportunity with the various top decision makers of the respective organizations, will eventually grow your business in Global market
  • Get to know more about your competitors are first-hand, learn more about their businesses, and discover their strengths and weaknesses, all of which can add to your business’s competitive edge.
  • Encounter new vendors and suppliers for your business
  • Real Benefits in New business - Many Organizations make deals and sign contracts at our Pharmatech- 2024.
  • We offer you the Website visibility to more than 35K visitors in less than 6 months
  • Promotional logo of your organization at our conference banner, website and other proceedings, branding and marketing material
  • Hosting session slots, poster awards, recognition in opening ceremony and complimentary registrations, exhibition/workshop booth, low-budget options.

Benefit of Association for Collaborators

  • No one in the world have this huge visitors towards Pharmatech- 2024 these is the best platform to show case your society.

Create long-lasting relationships with the peers

  • Promotional content and Logo of your Association at our conference banner, website and other proceedings, branding and marketing material will increase your subscribers/Members number by 20 %.
  • Our Website visibility to your Organization page can give a great impact for your association in the Global Market.
  • Your representatives can network with key conference delegates to update their knowledge and understanding of your organization and services.
  • Details will be added to the conference press release where the details will be shared to < 100000 outlets
  • Details will be incorporated in all conference promotional materials which will be distributed to Hospitals, Universities, Society and Researchers

Market Analysis

A market analysis for Pharmaceutical Development 2025 would focus on current trends, challenges, and opportunities within the pharmaceutical industry, with an emphasis on advancements, regulatory changes, and technological innovations. Here’s an overview of key areas to consider:

Industry Overview

  • Global Pharmaceutical Market Size: The pharmaceutical market is projected to reach over $1.5 trillion by 2025, driven by the aging global population, rising healthcare expenditures, and advancements in drug development.
  • Growth Rate: The market is expected to grow at a CAGR of approximately 6-7% during the forecast period (2020-2025).
  • Key Regions: North America, Europe, and Asia-Pacific are the leading regions, with the US and China dominating the market. Emerging markets like India and Brazil are experiencing rapid growth due to improved healthcare infrastructure.

Key Drivers

  • Innovations in Drug Discovery: Advances in biotechnology, genomics, and personalized medicine are accelerating drug discovery. Cutting-edge approaches like CRISPR, AI-based drug discovery, and biopharmaceuticals are reshaping the market.
  • Increased Demand for Generic Drugs: The patent expiration of major blockbuster drugs is driving the generic pharmaceuticals market, with growth particularly notable in developing regions.
  • Regulatory Support: Regulatory bodies like the FDA and EMA are adopting more flexible frameworks to expedite drug approval processes, particularly for orphan drugs, rare diseases, and innovative therapies.

Challenges

  • High R&D Costs: The rising cost of pharmaceutical research and development remains a significant challenge. On average, developing a new drug can take over 10 years and cost upwards of $2 billion.
  • Regulatory Hurdles: Despite supportive policies for innovation, strict regulations and lengthy approval processes can delay the time-to-market for new drugs.
  • Pricing Pressure: Governments and healthcare systems are increasingly focused on cost containment, which could lead to stricter pricing controls, particularly in the US and Europe.
  • Supply Chain Disruptions: The COVID-19 pandemic exposed vulnerabilities in global supply chains, particularly for active pharmaceutical ingredients (APIs). This has prompted companies to rethink supply chain resilience and consider reshoring some manufacturing.

Technological Advancements

  • Artificial Intelligence & Machine Learning: AI is being widely adopted in drug discovery, clinical trials, and predictive analytics, significantly reducing the time and cost required for pharmaceutical development.
  • mRNA Technology: The success of mRNA vaccines, like those developed for COVID-19, has opened new avenues for developing treatments for infectious diseases, cancers, and other conditions.
  • Precision Medicine: Personalized therapies tailored to individual patients’ genetic profiles are gaining momentum, especially in oncology and rare diseases.
  • 3D Printing: Advances in 3D printing are enabling personalized drug dosages and delivery systems, leading to more efficient treatments.

Opportunities

  • Biosimilars: As patents for many biologic drugs expire, the biosimilars market is growing rapidly, presenting a lucrative opportunity for pharmaceutical companies.
  • Expanding in Emerging Markets: Countries like China, India, and Brazil offer high growth potential due to increasing healthcare investments and expanding middle-class populations.
  • Telemedicine & Digital Health: The rise of telemedicine and digital health platforms is creating opportunities for pharmaceutical companies to integrate digital solutions into their product portfolios.

Key Players

  • Major pharmaceutical companies expected to lead the market in 2025 include Pfizer, Johnson & Johnson, Merck & Co., Roche, Novartis, Sanofi, GSK, and AstraZeneca.
  • Biotech firms like Amgen, Regeneron, and Gilead Sciences are also poised for growth, especially in the fields of oncology, rare diseases, and gene therapy.

                                                     

VISA-TripAdvisor

Planning a Trip to Vancouver, Canada!!! Attending Meeting!!!

An issue with VISA!!

Pharmatech 2025 Committee will be happy to help you in all regards to plan your trip to Vancouver, Canada. Avail the official invitation letter from us to attend this event ahead with a closer step for approval of your VISA.

Find out what you need to do to visit Canada as a tourist or business person, how to extend your stay in Canada and what documents you need to carry with you to transit through Canada.

Application submission:

Canada does not have a visa office in every country so it is important that Delegates/Attendees visit the website of the visa office responsible for processing their visa applications.  Information is available on the website on how to submit a visa application and the documentation required. 

Delegates/Attendees are encouraged to submit their visa applications well in advance of the date of the event at a Visa Application Centre or on-line E-applications (e-Apps).

E-Apps

This system allows clients to submit applications online.

Delegates/Attendees that need a visa but require their passport for other travel purposes are strongly encouraged to submit their visa applications online (e-Apps).  Delegates/Attendees that choose to apply online will not have to submit their passport until a decision has been taken on their applications.  If required, the visa office will send the applicant instructions on how and where to send their passports to finalize the visa process.  

Visa Application Centres (VACs):

VACs are commercial service providers authorized by Canada to provide specific services to applicants. 

VACs provide a number of services including help applicants fill out forms, answer questions and ensure that applications are complete, thereby reducing unnecessary delays or refusals due to incomplete applications.

Applicants that are required to provide biometrics information as part of the visa application process can do so at a VAC.  Additional information on the biometrics requirements is available at the IRCC website.

VACs send applications to Visa Offices and transmit decisions to applicants in a secure and confidential manner. VACs do not process visa applications and play no role in the decision-making process.

Visa Applications Processing Time:

Processing time for visa applications vary depending on the office and the time of the year.  Participants should be encouraged to apply early for their visas, and to submit complete applications including all supporting documents.  

Please visit the IRCC website for information on the time it takes to process visa applications at the various visa offices. 

NEW - Electronic Travel Authorization (eTA)

As of March 15, 2016, visa-exempt foreign nationals are expected to have an Electronic Travel Authorization (eTA) to fly to or transit through Canada. Exceptions include U.S. citizens and travelers with a valid Canadian visa. Canadian citizens, including dual citizens, and Canadian permanent residents are not eligible to apply for an eTA.

However, from March 15, 2016, until fall 2016, travellers who do not have an eTA can board their flight, as long as they have appropriate travel documents, such as a valid passport. During this time, border services officers can let travellers arriving without an eTA into the country, as long as they meet the other requirements to enter Canada. We invite you to consult the IRCC website regularly for information updates on eTA.

Best Tourist Destination: Vancouver

  • Stanley Park
  • Granville Island
  • Grouse Mountain
  • Museum of Anthropology
  • Kitsilano Beach
  • Gastown
  • Canada Place
  • Chinatown
  • English Bay
  • Capilano Suspension Bridge
  • Robson Street
  • Museum of Vancouver
  • Queen Elizabeth Park
  • Science World
  • Richmond & Many more…

To Collaborate Scientific Professionals around the World

Conference Date June 10-11, 2025

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by